Tapping the Protein Tyrosine Phosphatase Family to Treat Human Diseases
Cellular immunotherapy in a pill
Tapping the Protein Tyrosine Phosphatase Family to Treat Human Diseases
Cellular immunotherapy in a pill
Cellular immunotherapy in a pill
Cellular immunotherapy in a pill
Our company is focused on the discovery of novel PTP inhibitors and harnessing their therapeutic potential
Our lead compound is ready for phase I testing against multiple cancer
We are actively seeking partnering opportunities, and collaborations with pharmaceutical and biotechnology companies to develop and commercialize our technologies
Copyright © 2024 Kanyrpharma - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.